Should Dukes' B patients receive adjuvant therapy? A statistical perspective

This publication has 12 references indexed in Scilit:

• Clinical Trial to Assess the Relative Efficacy of Fluorouracil and Leucovorin, Fluorouracil and Levamisole, and Fluorouracil, Leucovorin, and Levamisole in Patients With Dukes' B and C Carcinoma of the Colon: Results From National Surgical Adjuvant Breast and Bowel Project C-04
  Journal of Clinical Oncology, 1999
• Efficacy of Adjuvant Fluorouracil and Folinic Acid in B2 Colon Cancer
  Journal of Clinical Oncology, 1999
• Portal Vein Chemotherapy for Colorectal Cancer: a Meta-analysis of 4000 Patients in 10 Studies
  JNCI Journal of the National Cancer Institute, 1997
• Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer.
  Journal of Clinical Oncology, 1997
• Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer
  Gastroenterology, 1994
• The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03.
  Journal of Clinical Oncology, 1993
• Adjuvant therapy of Dukes' A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02.
  Journal of Clinical Oncology, 1990
• Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma
  New England Journal of Medicine, 1990
• Postoperative Adjuvant Chemotherapy or BCG for Colon Cancer: Results From NSABP Protocol C-011
  JNCI Journal of the National Cancer Institute, 1988
• Efficacy of adjuvant fluorouracil and folinic acid in colon cancer: International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators
  Published by Elsevier